Literature DB >> 11580081

Postal administration compared with nurse-supported administration of the QUALEFFO-41 in a population sample: comparison of results and assessment of psychometric properties.

P Murrell1, C J Todd, A Martin, J Walton, P Lips, J Reeve.   

Abstract

The objective of this study was to test the psychometric properties of the QUALEFFO-41, an osteoporosis-specific health-related quality of life (HRQoL) measure, in a population sample. The study involved repeated administration of QUALEFFO-41 and another measure of HRQoL, the SF-36, to a stratified random population sample to test reliability and validity of instrument. The study was set in urban Harrow, Middlesex, UK and rural Cambridgeshire, UK. The participants were 83 males and 88 females aged 65-80+ years. Of the 230 individuals contacted 76.5% participated. The test-retest reliability of most QUALEFFO-41 items was good (Kappa 0.59-0.91) but two items had lower repeatability. Internal consistency was also generally good, but suggestive of some redundancy for three domains. The QUALEFFO-41 domains in general correlated well with SF-36 domains (r = 0.57 to r = 0.87), suggesting good validity. The QUALEFFO-41 has been shown to be a reliable and valid disease-specific HRQoL measure for osteoporosis. In population samples, it can be administered by post, or with a professional available to answer queries. Some specific items perform less well than may be desired and there is evidence of some redundancy, but further investigation is required and there are not yet grounds for textual change. We recommend continued use of this well-validated, reliable instrument.

Entities:  

Mesh:

Year:  2001        PMID: 11580081     DOI: 10.1007/s001980170067

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  8 in total

1.  The reliability and validity of the simplified Chinese version of Male QUALEFFO-26.

Authors:  Leilei Xu; Weixiang Sun; Xiaodong Qin; Xiufen Zhu; Yong Qiu; Zezhang Zhu
Journal:  Rheumatol Int       Date:  2015-12-22       Impact factor: 2.631

2.  Validation of the simplified Chinese version of the quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO-31).

Authors:  Chuanwen Zhou; Qianjun Li; Shushu Huang; Lu Fan; Bingjian Wang; Jian Dai; Xiaoming Tang
Journal:  Eur Spine J       Date:  2015-06-14       Impact factor: 3.134

Review 3.  Quality of life in patients with osteoporosis.

Authors:  Paul Lips; Natasja M van Schoor
Journal:  Osteoporos Int       Date:  2004-12-18       Impact factor: 4.507

Review 4.  The impact of fragility fracture on health-related quality of life : the importance of antifracture therapy.

Authors:  Ted Xenodemetropoulos; Shawn Davison; George Ioannidis; Jonathan D Adachi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Content comparison of osteoporosis-targeted health status measures in relation to the International Classification of Functioning, Disability and Health (ICF).

Authors:  Michael Borchers; Alarcos Cieza; Tanja Sigl; Barbara Kollerits; Nenad Kostanjsek; Gerold Stucki
Journal:  Clin Rheumatol       Date:  2004-09-14       Impact factor: 2.980

6.  Cultural adaptation and validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) in a Mexican population.

Authors:  Esperanza Ramírez Pérez; Patricia Clark; Niels H Wacher; Mario H Cardiel; Ma del Pilar Diez García
Journal:  Clin Rheumatol       Date:  2007-07-24       Impact factor: 2.980

7.  Health-related quality of life and radiographic vertebral fracture.

Authors:  W Cockerill; M Lunt; A J Silman; C Cooper; P Lips; A K Bhalla; J B Cannata; R Eastell; D Felsenberg; C Gennari; O Johnell; J A Kanis; C Kiss; P Masaryk; M Naves; G Poor; H Raspe; D M Reid; J Reeve; J Stepan; C Todd; A D Woolf; T W O'Neill
Journal:  Osteoporos Int       Date:  2003-11-13       Impact factor: 4.507

8.  Factors influencing quality of life in Moroccan postmenopausal women with osteoporotic vertebral fracture assessed by ECOS 16 questionnaire.

Authors:  Fatima E Abourazzak; Fadoua Allali; Samira Rostom; Ihsane Hmamouchi; Linda Ichchou; Laila El Mansouri; Loubna Bennani; Hamza Khazzani; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Health Qual Life Outcomes       Date:  2009-03-13       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.